baber/WOPTO huggingface dataset:
Patent NZ-526806-A (NZ)
Title: Therapeutic film forming composition and treatment system
Inventor: DVORETZKY ISRAEL
IPC: A61M37/00
Filed: 2002-01-07
Abstract: A film forming composition incorporating one or more therapeutic substances for application to nails and/or skin surfaces which can be employed independently or, if desired, in combination with an easily employed holding or support member for delivering heat directly to the application site for treating nails and/or skin surfaces for a wide variety of medical problems is disclosed. The disclosed treatment system for providing an effective transdermal delivery of therapeutic agents possesses broad applicability for a wide range of medical conditions, including the numerous diseases, disorders, and medical problems, all of which are capable of being treated using this treatment system. In particular, diseases, disorders, and medical conditions which include, but are not limited to, psoriasis, skin cancers, warts, leishmaniasis, mycobacteria, and granuloma annulare can be specifically treated under controlled conditions due to the efficacy of heat penetration in treating these disorders.
Patent NZ-527068-A (NZ)
Title: Leash
Inventor: BIRD DARREN JAMES
IPC: A01K27/00
Filed: 2003-07-18
Abstract: An animal leash is provided which has a container (12) to which a strap (1) is attached for clipping to an animal collar (20). The container is substantially triangular shape and has a handle opposite the apex of the triangular shape that allows the user to pull on the leash. The strap (1) includes a slidable connector to allow the strap, when disconnected from the container, to be secured about an appropriate fixed or stationary object.
Patent NZ-527863-A (NZ)
Title: Variant neublastin polypeptides conjugated to polymeric molecules that exhibit enhanced pharmokinetic and bioavailability in vivo
Inventor: SAH DINAH W Y
IPC: A61K47/48
Filed: 2002-01-25
Abstract: A variant neublastin polypeptide suitable for formation of a conjugate comprising the variant neublastin polypeptide coupled to a polymer containing a polyalkylene glycol moiety is disclosed. The present conjugate has prolonged bioavailability and prolonged biological activity relative to non-modified or wild-type forms of neublastin. The conjugates are usefully employed in therapeutic as well as non-therapeutic, e.g., diagnostic, applications.
Patent NZ-528370-A (NZ)
Title: Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
Inventor: TROXLER THOMAS J
IPC: A61K31/437
Filed: 2002-04-02
Abstract: Compounds of formula (I) wherein R1 to R5 are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals for treating depression and anxiety.
Patent NZ-539898-A (NZ)
Title: Method of treatment of vegetable matter with ultrasonic energy
Inventor: BATES DARREN MILES
IPC: A23L27/60
Filed: 2003-11-03
Abstract: Disclosed herein is a method for modifying the viscosity of pureed vegetable matter that comprises the step of applying relatively low-frequency ultrasonic energy to said puree via a sonotrode in a manner such that cavitation of a water fraction in said puree is induced and the cellular structure and cell wall material of the vegetable matter are degraded, thereby to increase the viscosity of said puree.
Patent NZ-541008-A (NZ)
Title: Method of treating functional bowel disorders
Inventor: LANDAU STEVEN B
IPC: A61K31/551
Filed: 2004-01-13
Abstract: Disclosed is the use of a compound of Formula I for the manufacture of a medicament for treating a functional bowel disorder or for reducing pain or discomfort associated with irritable bowel syndrome (IBS).
Patent NZ-554082-A (NZ)
Title: Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
Inventor: LANIER MARION
IPC: A61K31/4162
Filed: 2005-10-19
Abstract: Pyrazolo [1,5-alpha] pyrimidinyl derivatives represented by the structural formula shown herein are disclosed, wherein the variables shown in structural formula are as defined in the specification. These compounds are corticotropin-releasing factor (CRF) receptor antagonists which may have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in mammals and are particularly suitable for treating neuropsychiatric disorder selected from the group of anxiety, depression and irritable bowel syndrome.
Patent NZ-555237-A (NZ)
Title: Financial products
Inventor: MCALARY MICHAEL
IPC: G06Q40/00
Filed: 2005-11-17
Abstract: An apparatus for providing a financial product from a first party to a second party is disclosed. The apparatus includes a processing system having a processor and a store. The processing system is configured to receive loan parameters relating to a loan from the first party to the second party; determine, using the loan parameters and a repayment rule, payments to be paid by the second party to the first party; determine, using the loan parameters and the repayment rule, a maximum allocation rate; and apply an allocation rate, which is less than or equal to the maximum allocation rate, to the payments to determine: a first portion of each payment used for at least partially repaying at least one of principal and interest on the loan; and a second portion of each payment used for at least partially acquiring an investment for the second party.
Patent NZ-566100-A (NZ)
Title: Acetylcysteine composition and uses therefor
Inventor: PAVLIV LEO
IPC: A61K47/18
Filed: 2006-05-30
Abstract: Disclosed is an aqueous pharmaceutical composition comprising between 200 and 250mg/ml acetylcysteine, wherein the composition is substantially free of EDTA or pharmaceutically acceptable salts thereof, wherein the pH of the composition is from 6 to 8, and wherein said composition is sealed in an airtight container comprising a fill volume of said composition and a headspace volume occupied by a pharmaceutically inert gas.
Patent NZ-567870-A (NZ)
Title: Dispensing device for attachment to an animal operable to enable flowable material within the dispensing device to be dispensed when the animal lifts its tail
Inventor: QUIN BERTRAM FRANCIS CHARLES
IPC: A01C21/00
Filed: 2008-05-02
Abstract: A device for dispensing a flowable substance is disclosed. The dispensing device has a reservoir to hold a quantity of a flowable substance, a retention means to attach the reservoir to an animal at a location adjacent to the tail of the animal, a valve to control the flow of substance out of the reservoir, and a control means having a tail engagement member and a valve actuation member. The valve actuation member has a first end which is linked to the valve and a second end which is linked to the tail engagement member where the tail engagement member engages with a tail of the animal. The control means is configured such that, in use, lifting of the tail of the animal causes the tail engagement member to move, thereby producing a movement of the valve actuation member that opens the valve. Upon opening of the valve a portion of the substance held in the reservoir is dispensed onto the ground.
Patent NZ-568783-A (NZ)
Title: Self-jacking mobile saw stand
Inventor: WISE ROBERT WILLIAM
Filed: 2008-06-03
Abstract: A collapsible, self-jacking mobile power tool stand (10) is disclosed. The stand has an elongated power tool bed (12) for supporting a power tool (11) and a handtruck-shaped bed support that is movable with respect to the power tool bed between stowed and extended positions. The support has an upper end slidably connected to the power tool bed, an intermediate lever arm portion (72, 74) and a distal foot portion (92) terminating in a free end and forming an angle with respect to the lever arm portion. The stand further has at least one swing-out leg (30, 32) having an upper end pivotally connected adjacent a first end (14) of the power tool bed and a distal free end (38) for contacting a support surface, and at least one strut (48, 50) having a first end pivotally connected adjacent the power tool bed first end and a distal second end pivotally connected to the bed support. The, or each, leg and strut are pivotable between stowed and extended positions. At least one wheel (100) is connected to the bed support for rolling the stand on the support surface when the bed support, strut or struts, and leg or legs are in their respective stowed positions and so that when the bed support, strut or struts, and leg or legs are in their respective extended positions the wheel is lifted from the support surface and the stand is primarily supported by the leg and the foot portion free ends.
Patent NZ-569667-A (NZ)
Title: Novel heteroaryl substituted benzothiazoles
Inventor: GRAVENFORS YLVA
IPC: C07D513/04
Filed: 2007-01-25
Abstract: Disclosed herein is a compound 2-[6-(methylamino)pyridine-3-yl]-1,3-benzothiazol-6-ol wherein one or more of the atoms are optionally a detectable isotope; as a free base or a pharmaceutically acceptable salt, solvate or solvate of a salt thereof. Also disclosed is { N-methyl-11C]-2-(6-(methylamino)pyridine-3-yl]-benzothiazole-6-ol. Use of said compounds in the manufacture of a medicament for measuring amyloid deposits in a subject, wherein the measuring of amyloid deposits comprises a) administering a detectable quantity of a composition comprising said compounds and b) detecting the binding of the compound to amyloid deposit in the subject. Such compounds are also useful in the treatment of Alzheimer's disease, familial Alzheimer's disease, cognitive deficit in Schizophrenia, Down 's syndrome and homozygotes for the apolipoprotein E4 allele.
Patent NZ-578309-A (NZ)
Title: Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
Inventor: STEGE JUSTIN T
IPC: A61K48/00
Filed: 2008-01-30
Abstract: Disclosed are polypeptides having a lignocellulolytic activity, e.g., a glycosyl hydrolase, a cellulase, an endoglucanase, a cellobiohydrolase, a beta- glucosidase, a xylanase, a mannanse, a xylosidase (e.g., a â- xylosidase), an arabinofuranosidase, and/or a glucose oxidase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention provides polypeptides that can enzymatically process (hydrolyze) sugarcane bagasse, i.e., for sugarcane bagasse degradation, or for biomass processing, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. In one embodiment, the invention provides thermostable and thermotolerant forms of polypeptides of the invention. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts; for example, the invention provides a multi-enzyme system that can hydrolyze polysaccharides in a bagasse component of sugarcane processed in sugar mills. The invention provides enzymes for the bioconversion of lignocellulosic residues into fermentable sugars; and these sugars can be used as a chemical feedstock for the production of ethanol and fuels, including biofuels such as bioethanol, biopropanol, biobutanol and biodiesels.
Patent NZ-584233-A (NZ)
Title: Pharmaceutical product comprising yeast having controllable release of the active pharmaceutical ingredient
Inventor: ASMUSSEN BODO
IPC: A61K9/52
Filed: 2008-08-21
Abstract: Disclosed herein is a pharmaceutical product for the controlled release of an active pharmaceutical ingredient, wherein the pharmaceutical product comprises the active pharmaceutical ingredient and a medically acceptable yeast that is capable of fermentation (preferably Saccharomyces cerevisiae, Saccharomyces carlsbergensis, Saccharomyces uvarum, Saccharomyces boulardii, Saccharomyces exiguus and Saccharomyces ludwigii, Candida famala, Candida stellata, Dekkera bruxellensis, Hanensula uvarum, Kluyveromyces lactis, Kluyveromyces lactis, Kluyveromyces thermotolerans, Metschnikowia pulcherrima, Torulaspora delbrueckii and mixtures thereof). Also disclosed are methods for the production of said pharmaceutical product and use of a medically acceptable yeast.
Patent NZ-584479-A (NZ)
Title: Method for preparing main hydrolysate by hydrolyzing plant fiber materials with concentrated sulfuric acid
Inventor: CHEN PEIHAO
IPC: C07H1/00
Filed: 2008-07-29
Abstract: Disclosed is a method for preparing main hydrolysate by hydrolyzing plant cellulose materials with concentrated sulfuric acid comprising steps of: (1) dissolving part of the plant cellulose materials by sulfuric acid solution thereby forming a first hydrolysate; (2) adding concentrated sulfuric acid with a concentration more than 80 wt% into the first hydrolysate when the sulfuric acid in the first hydrolysate can not dissolve the plant cellulose materials any more, and then adding another part of the plant cellulose materials thereby forming a second hydrolysate; and (3) repeating the step (2) when the sulfuric acid in the second hydrolysate can not dissolve the plant cellulose materials any more, until all the plant cellulose materials are completely hydrolyzed, thereby obtaining a main hydrolysate. This method can be advantageously incorporated into the technology of using cellulose to produce liquid fuel and chemical products which comprises steps of hydrolyzing cellulose to form a carbohydrate, such as an oligosaccharide or a monosaccharide, and fermenting the carbohydrate to produce liquid fuel and chemical products by using microorganisms.
Patent NZ-585942-A (NZ)
Title: Throttle valve for control valve never quite closes
Inventor: SPLIETHOFF NORBERT
IPC: F16K21/02
Filed: 2008-12-04
Abstract: A throttle valve having a valve seat 131 and a movable valve element 132 is used for limiting the maximum opening of a control valve that controls a process valve. The throttle valve is arranged so that irrespective of the position of the valve member 132 with respect to the seat 131, the valve provides a minimum passage 133, 134 to allow fluid flow through the valve sufficient for initiating an actuation of the process valve.
Patent NZ-594132-A (NZ)
Title: A sentinel unit for an it electrical distribution system having a floating reference conductor
Inventor: RUBYTHON GEOFFREY
IPC: H02H7/20
Filed: 2009-12-21
Abstract: 594132 Disclosed is a sentinel unit (19) for an IT electrical distribution system having a floating reference conductor (3) and at least two electrical conductors (5, 6) for supplying electrical power from a source (26) to a load (15). The sentinel unit (19) limits the current flowing in the reference conductor (3) to less than a first predetermined current threshold.
Patent NZ-595440-A (NZ)
Title: Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
Inventor: ZHANG XIAOKUI
IPC: A61K35/12
Filed: 2010-03-26
Abstract: Discloses the use of isolated natural killer cells comprising isolated CD56+, CD16-, placental intermediate natural killer cells in the manufacture of a composition for treating an individual with cancer.
Patent NZ-595541-A (NZ)
Title: Road guardrail assembly comprising overlapping rail sections and a deforming member, wherein the deforming member is biased such that it causes the rail section to deform laterally under a vehicle impact
Inventor: LEONHARDT PATRICK A
IPC: E01F15/00
Filed: 2010-03-15
Abstract: 595541 A roadway guardrail assembly (2) comprising overlapping rail sections (4). A downstream end portion of a first rail section overlaps with and is secured to an upstream end portion of a second rail section. A deforming member (310) is secured to the upstream end portion of the second rail section and extends laterally from a side, wherein on vehicle impact the deforming member slideably engages a side of the first rail section and laterally deforms the first rail section outwardly away from the second rail section.
Patent NZ-595595-A (NZ)
Title: System and method for hybrid course instruction
Inventor: LAINE KENDALL
IPC: G06Q10/00
Filed: 2010-04-07
Abstract: 595595 Disclosed is a system providing an electronic presentation. A console interface (210) of a console programmable computer provides a presentation control interface for directing visual content to a presentation display (220a, 220b) for viewing by a number of in-class participants (320). A camera (240) and a microphone (250) capture video data and audio date of a presenter (310) which is sent, along with the visual content, to one or more programmable computers (260). The data is then encoded and transmitted to a number of remote attendee systems (331) via a network. The programmable computers (260) are further configured to receive incoming data from the remote attendee systems (331) via the network, and in response, output audio via a speaker, and interact with the console programmable computer (260). A number of in-class programmable systems are each programmed to execute an educational exercise, and each come with a display and an input device for operation by the in-class participants (320). Out-of-class programmable systems (331) are programmed to execute the educational exercise and to be operated by a remote attendee system (331) via the network. Also included are a number of breakout programmable computer systems each having a breakout display, a breakout camera, a breakout microphone, a breakout speaker, and a breakout input device. Each breakout programmable computer is programmed to provide a virtual whiteboard on the breakout display for modifying a diagram in response to the breakout input device. Image data is received from the breakout camera and audio data from the breakout microphone and encoded into outgoing breakout data. This data is then transmitted to a subset of the remote attendee systems (331) via the network. Any modifications to the diagram made in response to the breakout input device are transmitted to the subset of the plurality of remote attendee systems (331). Encoded audio data from a remote attendee system (331) included in the subset of the plurality of remote attendee systems (331) is received and output via the breakout speaker. The one or more programmable computers (260) communicate with the remote attendee systems (331) only through a connection server which is configured to broadcast data received from the programmable computers (260) to the remote attendee systems (331).
Patent NZ-595901-A (NZ)
Title: Use of allopurinol for the treatment of hand foot skin reaction
Inventor: RODEMER YOLANDA
IPC: A61K9/00
Filed: 2010-04-29
Abstract: ABSTRACT - 595901 The disclosure relates to use of allopurinol or a pharmaceutically acceptable salt thereof for the treatment or prevention of Hand Foot Skin Reaction (HFSR) induced by Multitargeted Kinase Inhibitor (MKI) therapy, wherein the allopurinol or its salt is administered topically to the affected areas, palms and soles, preferably in the form of a hydrophilic cream.
Patent NZ-596357-A (NZ)
Title: Brushless DC motor with bearings
Inventor: MEBASSER SAMUEL AZIZ
IPC: F16C19/00
Filed: 2007-10-24
Abstract: 596357 Disclosed is a rotor-supporting structure for an electric motor. The rotor-supporting structure is comprised of a tube (322) having an interior surface, an exterior surface, at least one bearing support section (376) and an annular flange (374). The interior surface is structured to support a rotor (314) and magnet (316) of a motor (310) within the tube (322). The at least one bearing support section (376) is provided to at least one end of the tube (322) and is adapted to support a bearing (320). The tube (322) also has at least a portion that is sufficiently magnetically transparent to allow a magnetic field to pass through it. The annular flange (374) is provided on the exterior surface of the tube (322) and is structured to support and maintain a stator assembly (318) of the motor (310) in an operative position when assembled with a motor housing (362). A positive airway pressure device (360) having a motor (310) featuring such a rotor-supporting structure is also disclosed.
Patent NZ-596445-A (NZ)
Title: New compounds, pharmaceutical composition and methods relating thereto
Inventor: DYCK BRIAN
IPC: A61K31/15
Filed: 2010-06-23
Abstract: Disclosed herein are compounds of formula (I), wherein the variable are defined in the specification, and the use thereof in the treatment of a disease or condition mediated by modulating the activity of GPR119 in a patient. Exemplary compounds include: 2-(4-{ 4-[1-(5-ethyl-pyrimidin-2-yl)-piperidin-4-yloxyimino]-piperidin-1-yl} -2,5-difluoro-phenyl)-N-(1-methyl-piperidin-4-yl)-acetamide; 4-(1-{ 4-[(2-dimethylamino-ethylcarbamoyl)-methyl]-2,5-difluoro-phenyl} -5 piperidin-4-ylideneaminooxy)-piperidine-1-carboxylic acid isopropyl ester; and 1-(2-fluoro-4-methanesulfonyl-phenyl)-piperidin-4-one O-[1-(piperidine-1-carbonyl)-piperidin-4-yl]-oxime.
Patent NZ-598418-A (NZ)
Title: Controlled foam aqueous quaternary ammonium and phosphonium compositions
Inventor: SWEENY PHILIP GERDON
IPC: A01N33/12
Filed: 2007-10-25
Abstract: Disclosed is a method for controlling foam formation in an aqueous system containing at least one biocidal quaternary ammonium and/or phosphonium compound, wherein the at least one quaternary ammonium and/or phosphonium compound is selected from (i) a compound having the formula [QR1R2R3R4]*X- (l), wherein the substituents are as disclosed in the specification; (ii) a compound having the formula R19R20R21R22Q+X- (II), wherein the substituents are as disclosed in the description; (iii) a polymeric quaternary ammonium or phosphonium biocide; and (iv) a mixture of two or more quaternary compounds of any of (i) to (iii), said method comprising the addition of at least one anionic diester surfactant in a molar ratio of anionic surfactant to quaternary ammonium and/or phosphonium compound of 0.001 to 0.09, to said aqueous system. Also disclosed is the method of killing or inhibiting the growth of microorganisms, algae or fungi by applying the formulation above.
Patent NZ-599073-A (NZ)
Title: Primary oxidant feed to oxy-fired circulating fluidized bed (cfb)
Inventor: MARYAMCHIK MIKHAIL
IPC: B01J8/00
Filed: 2010-09-28
Abstract: 599073 A system for feeding a primary oxidant to an oxy-fired circulating fluidized bed (CFB) boiler. The system includes a plurality of bubble cap assemblies each comprising a stem and a bubble cap with at least one exit hole, each bubble cap connected via a stem to at least one windbox, the windbox containing at least one manifold. A plurality of pipes are provided, each pipe located within a bubble cap assembly with an open end located either at, above or below the exit holes of the bubble caps and an opposite end connected to the manifold located inside each windbox. Recycle gas is piped into the windbox, to the stem, and exiting from the exit holes located in the bubble cap into the CFB. Oxygen is piped into the manifold, through the pipes and exiting through the exit holes located in the bubble cap. The pipe may further contain means placed at its open end, to prevent accidental inlet of hot particles into the pipe, such as a debris shield placed above and proximate to the open end of the pipe or by having the open end oriented in a downward direction. An insulating gap may also be placed inside the bubble cap to reduce thermal conductance between the bubble cap outer surface that is exposed to hot bed material and the inner surface of the bubble cap, being in contact with oxygen.